Bank Of America Corp Oragenics Inc Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.11 - $15.59 $759 - $107,602
6,902 New
6,902 $0
Q1 2022

May 16, 2022
SELL
$0.33 - $0.56 $37 - $64
-115 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$0.43 - $0.69 $49 - $79
115 New
115 $0
Q3 2021

Nov 15, 2021
SELL
$0.58 - $0.84 $26 - $38
-46 Closed
0 $0
Q2 2021

Sep 13, 2021
BUY
$0.6 - $0.89 $27 - $40
46 New
46 $0

Others Institutions Holding OGEN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ORAGENICS INC

OGEN Quotes by TradingView
  • Ticker OGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 116,395,000
  • Market Cap $40.7M
  • Description
  • Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...
More about OGEN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email